Stem Cell Therapeutic and Research Reauthorization Act of 2026

United States119e CongrèsS-4109Senate
Mis à jour : 22 juin 2026

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Consulter le texte officiel

2 versions disponibles

Tous les dossiers disponibles sont affichés.

Chronologie

Dernière mesure du projet de loi complémentaire

HR-5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)

    Senate

  2. Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

    Senate

  4. Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

    Senate